Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,843,480
+$12,270,960 QoQ
Shares Held
1,748,000
0.0% QoQ
Ownership
3.81%
of shares outstanding
% of Portfolio
3.93%
of 13F equity value
Holder Rank
#6
of 151 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Octagon Capital Advisors LP holds $42,843,480 across 1 Drug Manufacturers - Specialty & Generic name. BIOA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
This page
|
1,748,000 | $42,843,480 |
All Filings in BIOA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,843,480 | 1,748,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,572,520 | 1,748,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,141,540 | 1,598,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||